The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Explore the hidden challenges faced by lung cancer patients in South Africa, where the definition of 'treatable' ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended by NICE for treating adults with ...

Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...

Tissue Biopsies: Tissue collection techniques include bronchoscopy, thoracoscopy, mediastinoscopy, etc. Once the tumor tissue ...

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...

The actress said that it was her first time having surgery and shared that the cancer was discovered during a routine health ...

The "Lung Cancer Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The ...

FDA approves AstraZeneca’s Imfinzi for limited-stage small cell lung cancer, cutting the risk of death by 27% in the ADRIATIC ...